Latest "Sanbe Farma" News Stories

15:45 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Sanbe Farma" found in our extensive news archives from over 250 global news sources.

More Information about Sanbe Farma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sanbe Farma for you to read. Along with our medical data and news we also list Sanbe Farma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sanbe Farma Companies for you to search.

Showing "Sanbe Farma" News Articles, all 13

Thursday 7th June 2018

Supporting the Wellbeing of Local Communities through Legal CARES Day

SOURCE: Astellas DESCRIPTION:On May 22, Astellas marked the inaugural Legal Community Advocacy, Representation and Service (CARES) Day, where employees from the Legal and Intellectual Property (IP) department around the world dedicated a day to volunteering in the communities where they live and work. This activity complements the company’s Changing Tomrrow Day, Astellas’ global day of service...

Monday 2nd April 2018

Mentor Capital 2017 Book Value Gains 57% to $6.3 Million in 10-K

Annual 10-K Filing for Marijuana and Cannabis M&A Company Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its annual 10-K filing for the year ended December 31, 2017 with the SEC. The Company reports that for the year ended December 31, 2017, Mentor had revenues of $3,182,700 and gross profit of $1,107,045 with a resulting n...

Friday 23rd March 2018

PT. Pyridam Farma Tbk PYFA Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryPT. Pyridam Farma Tbk Pyridam Farma is a medicinal products manufacturer that offers modern and traditional medicines. The company's products comprise antibiotics, vitamins, supplements, and traditional herbal care. Its products are used in therapeutic areas of analgesic, antipiretics, anti anemic, anti fungal, anti hypertension, anti parkinsonism, anti rheumatics, anti inflammatories, anti...

French Biotech Targets the Brain to Treat Cannabis Abuse

This week, we’re in Bordeaux, France, to visit Aelis Farma, a biotech developing a drug targeting the brain to treat cannabis abuse and other conditions. Mission: Aelis Farma is developing a new class of drugs known as signaling specific inhibitors (SSi) ... This awesome article French Biotech Targets the Brain to Treat Cannabis Abuse appeared first on Be kind and don't copy i...

Tuesday 13th March 2018

Grupo Farma Strategic SWOT Analysis Review [Report Updated: 21022018] Prices from USD $125

Grupo Farma Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by enab...

Friday 9th March 2018

Bionure Farma SL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryBionure Farma SL Bionure is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its lead candidate BN201 is being developed for the treatment of multiple sclerosis and other neurological...

Cadila and Kalbe advancing biosimilar ambitions

Indian generics maker Cadila Healthcare (Cadila) and Indonesia-based Kalbe Farma (Kalbe) are both making advances into the biosimilars field.

Thursday 8th March 2018

Faes Farma SA FAE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15022018] Prices from USD $250

SummaryFaes Farma SA Faes Farma develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, overthecounter medications and skincare treatment products. It exports rawmaterials and finished pharmaceutical products to pharmaceutical companies across the world. Faes Farma also owns Ingaso farm, the animal nutrition and healthcare company...

Thursday 1st March 2018

PT Kimia Farma Persero Tbk KAEF Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19022018] Prices from USD $250

SummaryPT Kimia Farma Persero Tbk Kimia Farma undertakes the manufacture, commercialization and distribution of pharmaceutical products. The company provides ethical prescription, generic, and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular an...

Wednesday 21st February 2018

Australian-developed rotavirus vaccine protects Indonesian newborns

Diarrhoea is one of the leading causes of child illness and death, and rotavirus is the most common cause of severe diarrhoea. As noted by MCRI’s Professor Julie Bines, without vaccination the disease would infect children worldwide under the age of five — irrespective of the environment they live in. The good news is that vaccines are currently available, with the World Health Organization ...

Thursday 25th January 2018

Dechra buys 2 Netherlands pharma firms for 340m

Veterinary pharma company Dechra said it was buying Netherlands-based AST Farma and Le Vet for 340m. Dechra said it would pay 75% in cash and the rest in new shares, which would be subject to a two...

Tuesday 16th January 2018

Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication

Leiden, the Netherlands, January 16, 2018 / B3C newswire / -- Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has ...

Thursday 22nd June 2017

Invent Farma / neuraxpharm Group announces the acquisition of FB Health in Italy

First acquisition made by Invent Farma / neuraxpharm following the creation of the Group by funds advised by Apax Partners in August 2016 Barcelona, Spain and Düsseldorf, Germany, 22nd June 2017 / Sciad Newswire / The Invent Farma / neuraxpharm Group (the Group), a leading speciality generics company focussed on CNS, today announced the acquisition of FB Health S.p.A. (FB Health), an Italy-based...

Quick Search


News Quicklinks